Inogen Reports Wider Q1 Net Loss and Negative Adjusted EBITDA Despite Revenue Growth

summarizeSummary

Inogen Inc. reported a 3.4% increase in first-quarter revenue to $85.1 million, but experienced a significantly wider GAAP net loss of $8.3 million and a shift to negative Adjusted EBITDA of $1.4 million.

check_boxKey Events

• Q1 Revenue Growth

  Total revenue increased 3.4% year-over-year to $85.1 million for the three months ended March 31, 2026, primarily driven by higher international demand.

• Wider Net Loss

  GAAP net loss significantly widened to $8.3 million, compared to $6.2 million in the prior year, reflecting increased operating expenses.

• Negative Adjusted EBITDA

  Adjusted EBITDA turned negative at $(1.4) million, a notable decline from a positive $0.036 million in the same period last year.

• Cash Position Decline

  Cash and cash equivalents decreased to $93.1 million as of March 31, 2026, from $103.7 million at December 31, 2025.

auto_awesomeAnalysis

Inogen Inc.'s first-quarter results present a mixed financial picture. While the company achieved a modest 3.4% year-over-year revenue growth, primarily driven by international sales, its profitability metrics deteriorated significantly. The GAAP net loss widened by 34.8%, and Adjusted EBITDA turned negative, indicating ongoing operational challenges despite increased sales. The decrease in cash and cash equivalents highlights a continued cash burn, which investors will closely monitor. Although the company initiated a share repurchase program, the operational losses are a more dominant factor in this quarter's performance.